Evidence map›Paper›PMID 25240255›Full record

ArticleBioorganic & medicinal chemistry letters2014

Synthesis and characterization of valyloxy methoxy luciferin for the detection of valacyclovirase and peptide transporter.

Zachary F Walls, Sheeba Varghese Gupta, Gordon L Amidon, Kyung-Dall Lee

Abstract read
In one paragraph

Article in Bioorganic & medicinal chemistry letters, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Zachary F Walls *Center for Molecular Drug Targeting (CMDT), Department of Pharmaceutical Sciences, College of Pharmacy, University of Michigan, Ann Arbor, Michigan 48109.
Sheeba Varghese Gupta *Center for Molecular Drug Targeting (CMDT), Department of Pharmaceutical Sciences, College of Pharmacy, University of Michigan, Ann Arbor, Michigan 48109.
Gordon L AmidonCenter for Molecular Drug Targeting (CMDT), Department of Pharmaceutical Sciences, College of Pharmacy, University of Michigan, Ann Arbor, Michigan 48109.
Kyung-Dall LeeCenter for Molecular Drug Targeting (CMDT), Department of Pharmaceutical Sciences, College of Pharmacy, University of Michigan, Ann Arbor, Michigan 48109.

Funding

USE OF MUCCOSAL CELL CARRIERS/EYZYMES IN ORAL ABSORPTIONR01GM037188 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI AMIDON, GORDON L · 1986 to 2013
$4.4M
Targeted Subcellular Delivery of Oligonucleotides and ProteinsR01AI047173 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LEE, KYUNG-DALL · 2001 to 2009
$2.2M
NIAID NIH HHS R01 AI047173NIGMS NIH HHS R01 GM037188
6 · The paper itself

Abstract

An amino acid ester derivative of luciferin (valoluc) was synthesized to mimic the transport and activation of valacyclovir. This molecule was characterized in vitro for specificity and enzymatic constants, and then assayed in two different, physiologically-relevant conditions. It was demonstrated that valoluc activation is sensitive to the same cellular factors as valacyclovir and thus has the potential to elucidate the dynamics of amino acid ester prodrug therapies in a functional, high-throughput manner.

Indexed as

BacteriaBiological TransportCarboxylic Ester HydrolasesFirefly LuciferinHEK293 CellsHigh-Throughput Screening AssaysHumansHydrolysisLuminescenceMembrane Transport ProteinsMolecular StructureSpecies SpecificityCarboxylic Ester HydrolasesFirefly LuciferinMembrane Transport ProteinsLuciferinPEPT1ProdrugVACVase

Identifiers

PMID25240255
PMCPMC4192071

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.